Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Accenture
US Department of Justice
Federal Trade Commission
Deloitte

Generated: April 26, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NEVIRAPINE

« Back to Dashboard

Drug Price Trends for NEVIRAPINE

Average Pharmacy Cost for NEVIRAPINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NEVIRAPINE 200 MG TABLET 00378-4050-91 0.17143 EACH 2018-12-19
NEVIRAPINE 200 MG TABLET 47781-0100-60 0.17143 EACH 2018-12-19
NEVIRAPINE 200 MG TABLET 31722-0505-60 0.17143 EACH 2018-12-19
NEVIRAPINE 200 MG TABLET 51991-0331-06 0.17143 EACH 2018-12-19
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for NEVIRAPINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NEVIRAPINE 200MG TAB Golden State Medical Supply, Inc. 60429-0298-60 60 14.15 0.23583 EACH 2018-01-01 - 2022-12-31 FSS
VIRAMUNE 200MG 14 TABLET BLISTER PACK Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0046-46 14 82.61 5.90071 EACH 2018-01-01 - 2020-03-31 FSS
VIRAMUNE 200MG TAB Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0046-60 60 359.89 5.99817 EACH 2018-01-01 - 2020-03-31 FSS
VIRAMUNE 50MG/5ML SUSP,ORAL Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0047-24 240ML 95.67 0.39863 ML 2018-01-01 - 2020-03-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Baxter
McKinsey
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.